1 

### Scheltema, Christina

From: Jessica Fernandez <jessica.fernandez@bayer.com> Sent: Friday, July 17, 2015 12:19 PM To: Scheltema, Christina Cc: BCSReg_Archive Subject: FW: Fenamidone Data Call-In, GDCI-046679-1446 Bayer Crop Science Attachments: Letter explaining pollinator data requirements.pdf; GDCI-046679-1446.Fenamidone.BayerCS.pdf

Importance: High

“ I, Jessica Fernandez, Registration Manager, have recei ved from U.S. EPA’s Offi ce of Pesticide Programs the pesticide DCI (GDCI-046679-1446 for fenamidone) on July 17, 2015 for Bayer CropScience LP. Additionally, I have successfully opened the file attachment(s) that accompanied the transmittal email. ”

Best regards,

Jessica Fernandez Federal Regulatory Affairs

Bayer CropScience LP BCS-REG-REGU Research Triangle Park, Tel: 919-549-2631 Mobile: 919-475-1100 E-mail: jessica.fernandez@bayer.com

From: Scheltema, Christina [mailto :Scheltema.Christina@epa.gov] Sent: Friday, July 17, 2015 11:08 AM To: Jessica Fernandez Cc: Jakob, Avivah; Sherman, Kelly; Nevola, Joseph Subject: Fenamidone Data Call-In, GD CI-046679-1446 Bayer Crop Science Importance: High

Dear Ms. Fernandez:

As part of the U.S. Environmental Protec tion Agency (EPA)’s pursuit of greater e fficiency and lower costs, the Agency plans to make greater use of the electron ic transmission of information. Histor ically, EPA’s Office of Pesticide Programs has sent paper Data Call-In (DCI) Noti ces by certified mail and a return-receipt card was signed/dated and returned to EPA. The Agency believes that sending DCIs el ectronically by e-ma il is more efficient.

This email message and the attached file co nstitute EPA’s electronic transmission of a DCI Notice to you. The DCI Notice requires you, a registrant of pesticide pr oducts containing the active ingredient fenamidone, to take certain steps and submit certain data to the EPA’s Office of Pesticide Programs , Pesticide Re-evaluation Division within the time frames provided in the DCI to maintain the continued registrati on of your product(s) containi ng the active ingredient(s).

Please open and read the attached file. You are required to send a complete and adequate e-mail response to the Agency acknowledging receipt of the original e-mail and DCI transmission by EPA. Within the next five business days, please respond to this e-mail transmissi on by “forwarding with attachments” your response by e-mail to EPA as follows:2 “ I, [ insert your name and title ], have received from U.S. EPA’s Office of Pesticide Programs the pesticide DCI (GDCI-046679-1446 for fenamidone) on [ insert date ] for [ insert registrant name as shown on the attached DCI Forms ]. Additionally, I have successfully opened the file attachment(s) that accompanied the transmittal e-mail. ”

If you are an agent for the registrant, include this additi onal information in the acknowledgement statement above:

“ I am the agent for [ insert registrant name as shown on the attached DCI Forms ]. ”

Send your acknowledgement e-mail with the original attachment(s) to me, the chemical review manager for fenamidone, Christina Scheltema, via e-mail, at scheltema.christina@epa.gov

.

The attached file contains the DCI Notice and its cover lette r, attachments, and instructions concerning the active ingredient

. As per the cover letter and instructions provided, see the DCI with its attachments. Within 90 days after your company receives this DCI Notice, you must respond to the DCI and its data requirements as further required by the DCI. Specific deadlines for submission of reports and dat a are set forth in the DCI and its attachments.

A copy of the DCI will be placed in the Registra tion Review docket for the active ingredient at www.regulations.gov . If you have any questions about the DCI or cannot open the atta chments, please contact the Chemical Review Manager, identified in Attachment 1: Data Call-In C hemical Status Sheet, by e-mail or letter.

Sincerely,

Christina Scheltema (703)308-2201 Pesticide Re-evaluation Division, Office of Pesticide Programs, U.S. Environmental Protection Agency

The information contained in this e-mail is for the exclusive use of the intended recipient(s) and may be confidential, proprie tary, and/or legally privileged. Inadvertent disclosure of this message does not constitute a waiver of any privilege. If you receive this message in error, please do not directly or indirectly use, print, copy, forward, or disclose any part of this message. Please also delete this e-mail and all copies and notify the sender. Thank you.

For alternate languages please go to http://bayerdisclaimer.bayerweb.com